Swiss biotech Idorsia has suffered a setback in its bid to develop clazosentan for a form of stroke in the west, despite winning approval of the drug in Japan last year. The company's global phase 3 ...
Stay ahead of the SEO and AI game with these 2026 Enterprise SEO trends. Discover what's new and how to adapt your marketing for future success. Enterprise SEO is at the center of some fascinating and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback